Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Tandem Diabetes Care Company Profile (NASDAQ:TNDM)

Consensus Ratings for Tandem Diabetes Care (NASDAQ:TNDM) (?)
Ratings Breakdown: 1 Hold Rating(s), 6 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.80 (53.05% upside)

Analysts' Ratings History for Tandem Diabetes Care (NASDAQ:TNDM)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/8/2014Cowen and CompanyInitiated CoverageOutperform$16.00ViewTweet This Rating  Share This Rating on StockTwits
11/4/2014Northcoast ResearchInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
10/27/2014WedbushInitiated CoverageOutperform$20.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014Feltl & Co.Initiated CoverageStrong-BuyViewTweet This Rating  Share This Rating on StockTwits
8/1/2014Bank of AmericaUpgradeNeutral -> BuyViewTweet This Rating  Share This Rating on StockTwits
8/1/2014Deutsche BankReiterated RatingBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
7/15/2014William BlairInitiated CoverageOutperform$2.00ViewTweet This Rating  Share This Rating on StockTwits
5/14/2014Deutsche BankUpgradeHold -> Buy$28.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
3/20/2014Sterne AgeeInitiated CoverageNeutral$26.00ViewTweet This Rating  Share This Rating on StockTwits
12/9/2013Bank of AmericaInitiated CoverageNeutral$27.00ViewTweet This Rating  Share This Rating on StockTwits
12/9/2013Stifel NicolausInitiated CoverageBuy$30.00ViewTweet This Rating  Share This Rating on StockTwits
12/9/2013Deutsche BankInitiated CoverageHold$26.00ViewTweet This Rating  Share This Rating on StockTwits
12/9/2013Piper JaffrayInitiated CoverageOverweightViewTweet This Rating  Share This Rating on StockTwits
5/6/2013Morgan StanleyUpgradeEqual WeightViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/17/2012 forward)